Fmoc-S-tert-butylthio-L-cysteine
Need Assistance?
  • US & Canada:
    +
  • UK: +

Fmoc-S-tert-butylthio-L-cysteine

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
Fmoc-Amino Acids
Catalog number
BAT-003839
CAS number
73724-43-3
Molecular Formula
C22H25NO4S2
Molecular Weight
431.60
Fmoc-S-tert-butylthio-L-cysteine
IUPAC Name
(2R)-3-(tert-butyldisulfanyl)-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid
Synonyms
Fmoc-L-Cys(StBu)-OH; Fmoc-Cys(S-t-Bu)-OH; Fmoc-Cys(tButhio)-OH; Nalpha-Fmoc-S-tert-butylthio-L-cysteine; N-Fmoc-S-tert-butylthiol-L-cysteine
Appearance
White to off-white powder
Purity
≥ 99.5% (Chiral HPLC)
Density
1.281±0.06 g/cm3
Melting Point
73-77 °C
Boiling Point
623.0±55.0 °C
Storage
Store at -20 °C
InChI
InChI=1S/C22H25NO4S2/c1-22(2,3)29-28-13-19(20(24)25)23-21(26)27-12-18-16-10-6-4-8-14(16)15-9-5-7-11-17(15)18/h4-11,18-19H,12-13H2,1-3H3,(H,23,26)(H,24,25)/t19-/m0/s1
InChI Key
ZDUMTHLUTJOUML-IBGZPJMESA-N
Canonical SMILES
CC(C)(C)SSCC(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

Fmoc-S-tert-butylthio-L-cysteine, a versatile reagent in peptide synthesis, boasts unique properties that open doors to a myriad of applications in bioscience. Here are four key applications:

Peptide Synthesis: Widely embraced in solid-phase peptide synthesis (SPPS), Fmoc-S-tert-butylthio-L-cysteine shines with its Fmoc (9-fluorenylmethoxycarbonyl) protective group, offering both stability and easy removal. This compound plays a pivotal role in crafting peptides with cysteine residues crucial for establishing disulfide bonds. Such capability is indispensable for fashioning intricate peptides and proteins that mirror natural structures and functions.

Protein Engineering: Delving into the world of protein engineering, Fmoc-S-tert-butylthio-L-cysteine empowers the strategic incorporation of cysteine residues at specific positions within a protein sequence. This strategic maneuver allows for site-specific modifications, such as introducing fluorescent probes or other biochemical tags. These modifications stand as linchpins for delving into protein structure, function, and interactions across a spectrum of research and diagnostic endeavors.

Drug Design and Development: Spearheading the frontier of drug design and development, Fmoc-S-tert-butylthio-L-cysteine plays a pivotal role in crafting peptide-based drugs, where the inclusion of cysteine residues can amplify pharmacological properties. The ability to seamlessly introduce cysteine fosters the creation of peptides capable of establishing stable disulfide bonds, thereby enhancing their stability and bioavailability. This application shines bright in the quest to engineer therapeutic peptides tailored to combat conditions like cancer and infectious disease.

Bioconjugation: Stepping into the realm of bioconjugation techniques, Fmoc-S-tert-butylthio-L-cysteine emerges as a cornerstone for erecting bridges between peptides and a plethora of biomolecules, including proteins, nucleic acids, or small molecules. The cysteine residue houses a reactive thiol group capable of forging covalent bonds with diverse entities, paving the way for the creation of multifunctional bioconjugates that stand at the forefront of novel diagnostic tools, therapeutic agents, and targeted delivery systems.

1. Photomodulation of conformational states. Synthesis of cyclic peptides with backbone-azobenzene moieties
R Behrendt, M Schenk, H J Musiol, L Moroder J Pept Sci. 1999 Nov;5(11):519-29. doi: 10.1002/(SICI)1099-1387(199911)5:113.0.CO;2-3.
The search for photoresponsive conformational transitions accompanied by changes in physicochemical and biological properties led us to the design of small cyclic peptides containing azobenzene moieties in the backbone. For this purpose, (4-aminomethyl)phenylazobenzoic acid (H-AMPB-OH) and (4-amino)phenylazobenzoic acid (H-APB-OH) were synthesized and used to cyclize a bis-cysteinyl-octapeptide giving monocyclic derivatives in which additional conformational restriction could be introduced by conversion to bicyclic structures with a disulphide bridge. While synthesis with H-AMPB-OH proceeded smoothly on a chlorotrityl-resin with Fmoc/tBu chemistry, the poor nucleophilicity of the arylamino group of H-APB-OH required special chemistry for satisfactory incorporation into the peptide chain. Additional difficulties were encountered in the reductive cleavage of the S-tert-butylthio group from the cysteine residues since concomitant reduction of the azobenzene moiety took place at competing rates. This difficulty was eventually bypassed by using the S-trityl protection. Side-chain cyclization of the APB-peptide proved to be difficult, suggesting that restricted conformational freedom was already present in the monocyclic form, a fact that was fully confirmed by NMR structural analysis. Conversely, the methylene spacer in the AMPB moiety introduced sufficient flexibility for facile and quantitative side-chain cyclization to the bicyclic form. Both of the monocyclic peptides and both of the bicyclic peptides are photoresponsive molecules which undergo cis/trans isomerization reversibly.
2. Trimethoxyphenylthio as a highly labile replacement for tert-butylthio cysteine protection in Fmoc solid phase synthesis
Tobias M Postma, Matthieu Giraud, Fernando Albericio Org Lett. 2012 Nov 2;14(21):5468-71. doi: 10.1021/ol3025499. Epub 2012 Oct 17.
Trimethoxyphenylthio (S-Tmp) is described as a novel cysteine protecting group in Fmoc solid phase peptide synthesis replacing the difficult to remove tert-butylthio. S-Tmp and dimethoxyphenylthio (S-Dmp) were successfully used for cysteine protection in a variety of peptides. Moreover, both groups can be removed in 5 min with mild reducing agents. S-Tmp is recommended for cysteine protection, as it yields crude peptides of high purity.
Online Inquiry
Verification code
Inquiry Basket